Medline Inc. Class A Common Stock annual operating income for fiscal TTM was $2.0 billion, a decrease of 7.3% from $2.2 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Income (EBIT) | $2.0B | $2.2B | $2.2B | $1.4B | $870M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | $422M | $425M | $574M | $629M | $591M | $574M | $516M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MDLN metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All MDLN financial statements → Interactive MDLN charts →
About TickerBase · Data methodology & sources